ÇOCUKLARDA HENOCH SCHÖNLEİN PURPURASI, GASTROİNTESTİNAL SİSTEM TUTULUMU VE TEDAVİSİ
Amaç:Henoch-Schönlein purpurası çocukluk çağının IgAaracılığı ile oluşan otoimmün vaskülitidir. Genelliklepurpurik döküntü, karın ağrısı, artrit veya hematüri ile ortaya çıkmaktadır. Gastrointestinal tutulumlu çocuklardakarın ağrısı sık bir yakınmadır. Bu çalışmada; Henoch-Schönlein purpuralı çocuklarda gastrointestinal sistemtutulumunu ve onun steroidle tedavisini araştırdık.Gereç ve Yöntem:Aralık 2005 ileAralık 2007 arasındaki iki yıllık sürede Henoch-Schönlein purpurası tanısıylaizlenen hastalar çalışma grubunu oluşturdu. Gastrointestinal tutulumu olan hastalara düşük doz steroid kullanıldı.Bulgular:Toplam 31 hastanın üçünde (%9,6) hafif, beşinde (%16,1) ağır karın ağrısı, beşinde (%16,1) isegaitada belirgin ve/veya gizli kanama saptandı.Sonuç: Henoch-Schönlein purpuralı çocuklarda gastrointestinal tutulumu yaklaşık %60 sıklıkta ve bu sisteminağır tutulumunun tedavisinde steroidi etkili bulduk
Gastrointestinal System Involvement and Its Treatment in ChildrenWith Henoch-Schonlein Purpura
Purpose: Henoch Schönlein purpura is an IgA-mediated autoimmune vasculitis of children. It often presents with symptoms including purpuric rash, abdominal pain, renal involvement or arthritis. Abdominal pain is a frequent symptom in children with gastrointestinal involvement. We sought to evaluate gastrointestinal involvement in children with Henoch Schönlein purpura and the efficiency of steroid treatment of this condition. Materials and Methods: Aretrospective study of 31 patients diagnosed with Henoch-Schönlein purpura between December 2005 and December 2007 was conducted. Low dose steroid was used in children with gastrointestinal involvement. Results: Of the 31 patients, 3 (9.6%) had mild abdominal pain, 5(16.1%) colicy abdominal pain and 5 (16.%) suffered either overt gastrointestinal bleeding or had positive stool occult blood. Conclusion: We found gastrointestinal involvement in about 60% of children with Henoch-Schönlein purpura and steroid treatment in cases with severe involvement was effective.
___
- 1. Coppo R, Amore A. Henoch-Schonlein purpura. In:
Avner AD, Harmon WE, Niaudet P, editors. Pediatric
Nephrology, 5th ed. Philadelphia: Lippincott
Williams&Wilkins 2004: 851-63.
- 2. Cassidy JT, Petty RE. Henoch-Schönlein purpura.
Textbook of Pediatric Rheumatology. Tokyo: W.B.
Saunders Company, 1995: 384-88.
- 3. Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F.
Clinical outcome in children with Henoch-Schönlein
nephritis. Pediatr Nephrol 2007; 22: 6470.
- 4. Chang WL, Yang YH, Lin YT, Chiang BL.
Gastrointestinal manifestations in Henoch-Schönlein
purpura: a review of 261 patients. Acta Paediatr 2004;
93: 1427-31.
- 5. Cakir M, Orhan F, Mungan I, et al. Henoch-Schönlein
purpura in north-eastern Turkey. Ann Trop Paediatr
2006; 26(1): 59-65.
- 6. Aksu N, Akın M, Yavaşcan Ö, Erdoğan H, ve ark.
Henoch-Schönlein sendromlu çocuklarda
gastrointestinal sistemin endoskopi ve radyolojik
yöntemlerle değerlendirilmesi. Nefroloji Dergisi 2001;
10(2); 98102.
- 7. Lin SJ, Chao HC, Huang JL. Gastrointestinal
involvement as the initial manifestation in children
with Henoch-Schönlein purpura; clinical analysis of 27
cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za
Zhi. 1998; 39(3):18690.
- 8. Shin JI, Lee JS, Chung KS. Dapsone therapy for
Henoch-Schonlein purpura. Arch Dis Child 2006;
91(8): 714.
- 9. Shimomura N, Kawai K, Watanabe S, Katsuumi K, Ito
M. Adult Henoch-Schönlein purpura with severe
abdominal pain treated with dapsone and factor XIII
concentrate. J Dermatol 2005; 32(2):124-7.
- 10. Mills JA, Michel BA, Bloch DA, Calabrese LH,
Hunder GG, Arend WP, et al. The American College of
Rheumatology 1990 criteria for the classification of
Henoch-Schönlein purpura. Arthritis Rheum 1990; 33:
1114-21.
- 11. Akalın F, Çalışkan S, Sever L, ve ark. HenochSchönlein
purpuralı çocuklarda klinik bulgular ve akut
faz reaktanları ilişkisi. İstanbul Çocuk Kliniği Dergisi
1993; 28: 106-11.
- 12. Gülcan EM. Henoch-Schönlein purpuralı çocuklarda
gastrointestinal sistem tutulumunun klinik ve
laboratuar bulguları. Bakırköy Tıp Dergisi 2007; 3(3):
94-100.
- 13. Gardner-Medwin JMM, Dolezalova P, Cummins C,
Southwood TR. Incidence of Henoch-Schonlein
purpura, Kawasaki disease, and rare vasculitides in
children of different ethnic origins. Lancet 2002; 360:
1197-1202.
- 14. Ebert EC. Gastrointestinal manifestations of HenochSchonlein
purpura. Dig Dis Sci 2008; 53(8): 2011-9.
- 15. Schwab J, Benya E, Lin R, Majd K. Contrast enema in
children with Henoch-Schonlein purpura. J Pediatr
Surg 2005; 40:1221-3.
- 16. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E,
Falcini F, et al. Henoch Schonlein purpura in
childhood: epidemiological and clinical analysis of 150
cases over a 5-year period and review of literature.
SeminArthr Rheum 2005; 35(3):143-53.
- 17. Saulsbury FT. Henoch-Schonlein purpura in children.
Report of 100 patients and review of the literature.
Medicine 1999; 78(6): 395-409.
- 18. Lindenauer SM, Tank ES. Surgical aspects of HenochSchonlein's
purpura. Surgery 1960; 59(6): 982-7.
- 19. Cull DL, Rosario V, Lally KP, Ratner I, Mahour GH.
Surgical implications of Henoch-Schonlein purpura. J
Pediatr Surg 1990; 25(7): 741-3.
- 20. Wu CS, Tung SY. Henoch-Schonlein purpura
complicated by upper gastrointestinal bleeding with an
unusual endoscopic picture. J Clin Gastroenterol 1994;
19(2): 128-31.
- 21. Yavuz H, Arslan A. Henoch-Schonlein purpura-related
intestinal perforation: a steroid complication? Pediatr
Int 2001; 43(4): 423-5.
- 22. Connolly B, O'Halpin D. Sonographic evaluation of the
abdomen in Henoch-Schonlein purpura. ClinRadiol
1994; 49(5): 320-3.
- 23. Ozdemir H, Iik S, Buyan N, Hasanolu E. Sonographic
demonstration of intestinal involvement in HenochSchonlein
syndrome. Eur J Radiol 1995; 20(1): 32-4.
- 24. Narin N, Akcoral A, Aslin MI, Elmastas H. Ranitidine
administration in Henoch-Schonlein vasculitis. Acta
Pediatr Jap 1995; 37(1):37-9.
- 25. Fagbemi Andrew AO, Torrento F, Hilson Andrew JW,
Thomson MA, Heuschkel RB, Murch, SH. Massive
gastrointestinal haemorrhage in isolated intestinal
Henoch-Schonlein purpura with response to
intravenous immunoglobulin infusion. Eur J Pediatr
2007; 166:915-9.
- 26. Gonzalez-Gay MA, Llorca J. Controversies on the use
of corticosteroid therapy in children with HenochSchonlein
purpura. Semin Arthr Rheum 2005;
35(3):135-7.
- 27. Ronkainen J, Koskimies O, Ala-Houhala M,
Antikainen M, Merenmies J, Rajantie J, Ormala T,
Turtinen J, Nuutinen M. Early prednisone therapy in
Henoch-Schonlein purpura: a randomized, doubleblind,
placebo-controlled trial. J Pediatr 2006; 149(2):
241-7.
- 28. Huber AM, King J, McLaine P, Klassen T, Pothos M. A
randomized, placebo-controlled trial of prednisone in
early Henoch Schonlein Purpura BMC. Medicine
2004; 2: 7.